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Deconvolution-based analysis of CT and MR brain perfusion data is widely used in clinical practice and it is still a topic of ongoing
research activities. In this paper, we present a comprehensive derivation and explanation of the underlying physiological model for
intravascular tracer systems. We also discuss practical details that are needed to properly implement algorithms for perfusion
analysis. Our description of the practical computer implementation is focused on the most frequently employed algebraic
deconvolution methods based on the singular value decomposition. In particular, we further discuss the need for regularization in
order to obtain physiologically reasonable results. We include an overview of relevant preprocessing steps and provide numerous
references to the literature. We cover both CT and MR brain perfusion imaging in this paper because they share many common
aspects. The combination of both the theoretical as well as the practical aspects of perfusion analysis explicitly emphasizes the
simpliﬁcationstotheunderlyingphysiologicalmodelthatarenecessaryinordertoapplyittomeasureddataacquiredwithcurrent
CT and MR scanners.
1.Introduction
Tissueperfusionmeasurementfromiodinatedcontrastagent
enhancement on CT scans was ﬁrst proposed by Axel in
1980 [1]; this was based on earlier developments by Meier
and Zierler [2] for measuring blood ﬂow and blood volume.
At that time, the CT-based measurements were strictly
limited to research because of the low speeds and narrow
coverage of the existing CT scanners. However, the intro-
duction of perfusion CT (PCT) helped expand the utility of
CT signiﬁcantly since it could now provide capillary level
hemodynamic information. Within about a decade, per-
fusion imaging techniques were also adopted in MR [3–5].
With the advent of helical scanners and faster rotating
gantries (0.33–0.5s/rotation) in conjunction with multide-
tector geometries which provide larger coverage, PCT has
now become part of the routine screening for many diseases.
Given the existing developments in perfusion imaging,
the purpose of this paper is to focus on a detailed derivation
of the theoretical model for deconvolution-based perfusion
measurement. While the main equation of this model is well
known, its derivation is spread over several publications.
We therefore ﬁrst present a summary of the derivation,
with the aim of fully explaining the parameters and the
underlying assumptions that are made. Based on the main
equationofthetheoreticalmodel,wealsopresentaguideline2 International Journal of Biomedical Imaging
for the algorithmic implementation of the deconvolution-
based perfusion measurement. We discuss robust numer-
ical deconvolution and discuss topics related to data pre-
processing, providing references to the literature for each of
the special topics. The overall aim of this paper is to provide
an understanding of the underlying assumptions of the
theoretical model and to show how the (simpliﬁed) model
can be robustly implemented for clinical image analysis.
2. ClinicalApplications of Perfusion Imaging
Perfusion imaging is most widely used in acute stroke and
oncology [6]. When used in diagnosis of stroke, the purpose
of perfusion imaging is to identify the extent of aﬀected
tissue and to delineate the ischemic tissue that can be
reperfused. In oncology, perfusion imaging helps to identify
angiogenetic tumors that alter the local tissue perfusion due
to generation of neovasculature. Perfusion measurements
are increasingly being used for assessment, staging, and
monitoring posttherapy [6, 7].
Figure 1 shows common parameter maps based on
a brain perfusion CT exam (Somatom Deﬁnition AS+,
Siemens AG, Healthcare Sector, Forchheim, Germany) of a
69-year-old male stroke patient. The patient presented to the
hospital with an acute high-grade hemiparesis on the right
side.ACTangiographyscanindicatedanocclusionoftheleft
middlecerebralartery.Thetime-to-peak(TTP)imageshows
a large lesion that illustrates the maximum aﬀected tissue.
In addition, the cerebral blood ﬂow (CBF), cerebral blood
volume (CBV), and mean transit time (MTT) images exhibit
perfusion deﬁcits in a smaller brain territory. In general,
these perfusion CT maps are interpreted appropriately in
order to guide the recanalization procedure of the occluded
vessel.
Blood ﬂow is critical to the functionality of any organ
since it provides the essential nutrients and oxygen. In case
of ﬂow disruption, the body autoregulates the ﬂow and
pressure either by altering blood ﬂow or volume or both.
In the brain, there are some fairly well-deﬁned thresholds
for the cerebral blood ﬂow in normal, reversibly damaged,
and necrotic tissue. The normal value for the cerebral blood
ﬂow is between 50 and 60mL/100g/min for grey matter
[8]. The average value decreases with age and is about 2
to 3 times lower in white matter compared to grey matter
[9]. Any reduction in normal perfusion pressure results
in vasodilation and hence an increase in blood volume
and transit times. As the perfusion pressure falls lower,
compensatory vasodilation is unable to oﬀset the deﬁcit.
When this value falls below 20mL/100g/min (for grey
matter), synaptic transmission ceases to function. When the
ﬂow is below 8–10mL/100g/min, the cell membrane pumps
fail, causing irreversible damage to the cells [6].
2.1. Perfusion CT. In the acute stroke setting, conventional
CT has been the imaging modality of choice for ruling
out intracerebral hemorrhages (ICH). However, overall the
sensitivity of CT for stroke detection is 60–65% [10, 11]. For
ischemic stroke, which represents about 85% of all stroke
cases, the inclusion of PCT along with CT angiography
(CTA) can identify the subtle abnormalities in the cerebral
tissue that can be missed on the noncontrast agent-enhanced
scans. Most commonly, the perfusion scan consists of
imaging one or two slices at the level of the basal ganglia.
This allows inclusion of the branches of the carotid artery
that are typically thrombosed. After approximately 7–10s
following an intravenous injection of iodinated contrast
agent, continuous scanning is performed for about 50s.
Table toggling techniques are sometimes used to increase
the coverage. More recent wide detector scanners allow
whole brain coverage in each scan. The temporal scans are
reconstructed and one of several approaches can be used to
calculate the perfusion parameters.
In animal studies, the product of CT cerebral blood
volume (CBV) and ﬂow (CBF) from CT measurements
was found to have sensitivity of 90.6% and speciﬁcity
of 93.3% (compared with histological measurements) for
discerning ischemic and oligemic tissue [12]. One study
that compared stroke diagnosis using CT perfusion plus
angiography, against MRI, found good correlation and no
signiﬁcant prognosis diﬀerences [13]. Typical PCT scans add
approximately 5 or less additional minutes to the scan time
with around a 50mL bolus of additional iodinated contrast
agent. With regards to the X-ray dose in PCT, depending on
the parameters, the eﬀective dose is estimated to be between
1.2mSv [6]a n d3 . 4m S v[ 14]. This is in the same range as the
eﬀective dose of a standard cerebral CT, which is reported to
deliver about 2.5mSv to the patient [14].
The gold standard for perfusion CT has been imaging
with stable xenon as the contrast agent [7, 15]. This method
involves inhalation of a mixture of stable xenon gas and
oxygen followed by CT scanning. Because of the high atomic
number of xenon, it serves as a radio-opaque contrast agent
as it diﬀuses into the blood and neurons in a well-balanced
manner. It has been proven to be accurate in quantifying
perfusionbycomparingtheresultswiththoseobtainedusing
radio-labeled microspheres.
2.2. Perfusion MR. Perfusion imaging in MR can be per-
formed with or without contrast agent [16]. Noncontrast
agent-enhanced perfusion imaging usually uses spin labeling
of blood entering the imaging volume. This method is
less commonly used because of the increased sensitivity
to motion and related artifacts and low signal in case
of slow ﬂow. Gadolinium-based tracers such as Gd-DTPA
are more commonly used for measuring perfusion derived
from changes in the local susceptibility. Both spin echo
(SE) and gradient echo (GRE) sequences have been applied
successfully in perfusion MR. GRE sequences are most
frequently used because they provide a better contrast-to-
noise ratio for imaging of the contrast agent compared
to SE sequences [17–19]. However, GRE sequences have
the disadvantage of disproportionately weighting the con-
tribution of the contrast agent in relatively large vessels,
whereas SE sequences provide a more accurate assessment
of blood ﬂow through vessels of all sizes [19]. After the
7–10s interval that the gadolinium contrast agent takes
to reach the brain following the intravenous injection, the
signal in the cerebral tissue dips. The signal changes areInternational Journal of Biomedical Imaging 3
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Figure 1: CT perfusion parameter maps of cerebral blood ﬂow (CBF), cerebral blood volume (CBV), mean transit time (MTT), and time-
to-peak (TTP). The ischemic stroke lesion is marked with arrows.
most signiﬁcant over about 15s during which the change in
T2∗ or equivalently the change in the associated relaxation
rate R2∗ is monitored. Note that this also requires that the
contrast agent is intravascular. Rapid imaging (interval less
than 2s) is required for accurate measurement of perfusion
parameters. Typically echo-planar imaging (EPI) sequences
are used for this purpose.
3.TheoreticalModel
The aim of this section is to provide a compact outline of
bothsomeelementaryaswellaspracticallyrelevanttheoryof
perfusion estimation based on previous work. In particular,
we will introduce a theoretical physiological model of tissue
perfusion for intravascular tracer systems and present the
derivation of a deconvolution-based mathematical approach
for the estimation of diagnostically important perfusion
parameters. In addition, we will brieﬂy describe alternative
methods that do not require deconvolution.
3.1. Model of Microcirculation at the Tissue Level. For com-
puting the tissue perfusion, we assume a physiological model
of the blood supply to the tissue. Figure 2 shows this model
that consists of a volume of interest Vvoi covering the organ-
speciﬁc parenchyma, the interstitial space, and the capillary
bed. The volumes of the parenchyma and the interstitial
space are denoted by V
∗
voi, while the volume of the capillary
bed is referred to as Vcap. The entire volume of interest
Vvoi = V
∗
voi + Vcap shall be supplied with blood by a single
arterial inlet and correspondingly drained by a single venous
outlet. In general, it may have a diﬀerent shape than the
cuboidshowninFigure2.Abloodcellcantakevariouspaths
through the capillary bed. The transit time t it needs to pass
through the capillary bed depends on the chosen path. We4 International Journal of Biomedical Imaging
cart(t) cven(t)
interstitial space (V∗
voi)+v o l u m eo fc a p i l l a r yb e d( Vcap)
cvoi(t)
arterial inlet venous outlet
volume of interest (Vvoi) = volume of parenchyma and
Figure 2: Physiological model of the tissue perfusion. A blood cell
can take several paths through the capillary bed. The variables are
deﬁned in Table 1.
assume a stationary probability density distribution h(t)o f
transit times.
Once a contrast agent bolus has been injected, it enters
the volume Vvoi under consideration via the arterial inlet
and is then diluted into the capillary bed. The local contrast
agent concentrations cart(t)a n dcven(t) are measured directly
adjacent to the capillary bed on the arterial and venous
sides, respectively. Furthermore, the average contrast agent
concentration cvoi(t) within the volume of interest can
also be measured. In perfusion CT, an iodinated contrast
agent is used whereas, in perfusion MR, the measured
signal diﬀerence is created by a paramagnetic contrast agent
based on gadolinium (Gd) (see Section 2.2). The contrast
agent concentration is deﬁned as mass of iodinated contrast
agent per volume (unit: g/mL) or amount of Gd-based
contrast agent per volume (unit: mol/mL), respectively [20].
For the following analysis, we assume the contrast agent
c onc entrationt obemeasur edasmassperv olume,whic hcan
easily be related to amount per volume.
Figure 3 illustrates typical time-concentration curves
cart(t), cvoi(t), and cven(t) that may be measured in brain
tissue, for example. For the sake of simplicity, the maximum
contrast agent concentration has been normalized to 1. Note
thatthe(average)enhancementwithinthevolumeofinterest
is commonly more than an order of magnitude below the
enhancements of the feeding artery and the draining vein.
An additional important assumption is that the contrast
agent remains in the intravascular space. For our case of
cerebral perfusion, it should therefore not cross the blood-
brain barrier (BBB). As a consequence, this means that
all contrast agents entering from the arterial inlet will
eventuallyleave the volume of interest at the venous outlet. A
breakdownoftheBBBmayoccurintumorpatients,instroke
patients, and in patients that suﬀer from inﬂammations or
infections,forexample.Inthesecases,themethodspresented
in this paper may lead to inaccurate perfusion estimates
and particularly to an overestimation of the blood volume
[21, 22]. Note that there exist other modelling approaches
which do not assume that the contrast agent remains in the
intravascular space. These models can be used for measuring
tumor perfusion, for example [6, 20, 23].
Finally, we suppose that the contrast agent mixes per-
fectly with the blood and that the physical properties of the
blood (its ﬂow behavior, in particular) are not inﬂuenced by
the contrast agent.
As we will see, only knowledge of the functions cart(t)
and cvoi(t) is needed to compute the blood ﬂow within
the volume under consideration. In practice, the function
cart(t)—also known as the arterial input function (AIF)—is
not measured directly at the respective volume of interest,
but in a larger feeding artery in order to achieve a reasonable
signal-to-noise ratio (SNR) (see Section 4.1).
As a ﬁrst diagnostically relevant perfusion parameter, the
mean transit time (MTT) of the volume under consideration
is deﬁned as the ﬁrst moment of the probability density
function h(t) of the transit times, that is,
MTT =
  ∞
0
τh(τ)dτ. (1)
Furthermore, the residue (or residual) function r(t)—
compare [24]—represents an intermediate quantity of inter-
est and is deﬁned as
r(t) =
⎧
⎪ ⎨
⎪ ⎩
1 −
  t
0
h(τ)dτ,f o r t ≥ 0,
0, for t<0.
(2)
The (dimensionless) residue function thus quantiﬁes the
relative amount of contrast agent that is still inside the
volume Vvoi of interest at time t after an (idealized) delta-
shaped contrast agent bolus has entered the volume at the
arterial inlet at time t = 0; that is, cart(t) = δ(t). Due
to the various transit times within the capillary bed, the
contrast agent will not leave the volume instantaneously,
but gradually over time. In particular, this means that the
residue function decreases continuously from r(0) = 1t o0 .
Figure 4 shows typical examples of a distribution function
h(t) of transit times as well as the corresponding residue
function r(t). In this example, the function h(t) is modeled
by a gamma distribution [25].
3.2. Derivation of the Indicator-Dilution Theory. Using the
parameters deﬁned in Table 1, the accumulated masses of
contrast agent that have entered and left the volume of
interest during the time interval [0, t], denoted as mc,voi,in(t)
and mc,voi,out(t), respectively, can be expressed as
mc,voi,in(t) = F
  t
0
cart(τ)dτ,
mc,voi,out(t) = F
  t
0
cven(τ)dτ.
(3)
The volume ﬂow F is assumed to be constant over time. The
contrastagentconcentrationscart(t)andcven(t)atthearterial
inlet and the venous outlet, respectively, are time-dependent
functions which we assume to be 0 for t<0. These functions
primarily depend on the parameters of the contrast agent
injection and the patient’s cardiac cycle.International Journal of Biomedical Imaging 5
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Figure 3: Examples of the time-concentration curves cart(t), cvoi(t), and cven(t) given in arbitrary units (a.u.). (b) Represents a zoomed view
of (a) with a rescaled ordinate.
We can compute the mass mc,voi(t) of a contrast agent
within the volume of interest at time t using the principle of
conservation of mass as
mc,voi(t) = mc,voi,in(t) −mc,voi,out(t)
= F
  t
0
(cart(τ) − cven(τ))dτ.
(4)
The contrast agent concentration cven(t) at the venous
outlet can be computed from the contrast agent concen-
tration cart(t) at the arterial inlet by convolving it with the
probability density function h(t). We therefore obtain
cven(t) =
  +∞
−∞
cart(ξ)h(t −ξ)dξ. (5)
Notethatthroughoutthispaper,allintegralswithinﬁnite
integration endpoints shall be interpreted as the limit of the
integralwhentherespectiveendpointapproaches ±∞.Using
(5), we can rewrite (4), by applying the delta function δ(t),
as
mc,voi(t)
= F
  t
0
   +∞
−∞
cart(ξ)δ(τ −ξ)dξ −
  +∞
−∞
cart(ξ)h(τ −ξ)dξ
 
dτ.
(6)
Changing the order of integration and rearranging this
equation leads to
mc,voi(t) = F
  +∞
−∞
cart(ξ)
   t
0
(δ(τ −ξ) −h(τ −ξ))dτ
 
dξ.
(7)
By applying the substitution τ  = τ − ξ, recalling that, for
t ≥ 0, we have
r(t) = 1 −
  t
0
h(τ)dτ =
  t
0
(δ(τ) − h(τ))dτ, (8)
and considering that h(t) = 0f o rt<0, we obtain
  t
0
(δ(τ −ξ) −h(τ −ξ))dτ
=
  t−ξ
−ξ
(δ(τ
 ) −h(τ
 ))dτ
  = r(t −ξ).
(9)
Equation (7) thus eventually reads
mc,voi(t) = F
  +∞
−∞
cart(ξ)r(t −ξ)dξ. (10)
We introduce the cerebral blood ﬂow (CBF) as the blood
volume ﬂow normalized by the mass of the volume Vvoi,
CBF =
F
Vvoi ·ρvoi
. (11)
Inserting this deﬁnition into (10) yields
mc,voi(t)
Vvoi
= CBF ·ρvoi ·
  +∞
−∞
cart(ξ)r(t −ξ)dξ. (12)
According to Table 1, we deﬁne the contrast agent concentra-
tion cvoi(t) within the volume Vvoi of interest as
cvoi(t) =
mc,voi(t)
Vvoi
, (13)6 International Journal of Biomedical Imaging
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Figure 4: Examples of the distribution function h(t) of transit times (the mean transit time is 4 s) and the corresponding residue function
r(t).
Table 1: Summary of parameters used to derive the indicator-dilution theory and to deﬁne clinically relevant tissue perfusion quantities.
Variable Unit Description
Vvoi mL Total volume under consideration
Vcap mL Volume of the capillary bed within the volume Vvoi
V
∗
voi mL Volume Vvoi without the volume of the capillary bed, V
∗
voi = Vvoi −Vcap
ρvoi g/mL Mean density of the volume Vvoi
ρ
∗
voi g/mL Mean density of the volume V
∗
voi
mc,voi(t) g Total mass of contrast agent in volume Vvoi
cart(t) g/mL Local contrast agent concentration at the arterial inlet, cart(t) = dm/dV|t, measured at the arterial inlet
cven(t) g/mL Local contrast agent concentration at the venous outlet, cven(t) = dm/dV|t, measured at the venous outlet
cvoi(t) g/mL Average contrast agent concentration in the total volume Vvoi, cvoi(t) = mc,voi(t)/Vvoi
ccap(t) g/mL Average contrast agent concentration in the capillary bed, ccap(t) = mc,voi(t)/Vcap
c
∗
voi(t) g/mL Average contrast agent concentration corresponding to V
∗
voi, c
∗
voi(t) = mc,voi(t)/V
∗
voi
F mL/s Volume ﬂow at the arterial inlet and at the venous outlet
h(t) 1/s Probability density function of the transit times
which ﬁnally leads to the following formulation of the in-
dicator-dilution theory,
cvoi(t) = CBF ·ρvoi ·
  +∞
−∞
cart(ξ)r(t −ξ)dξ
= CBF ·ρvoi ·(cart ∗r)(t),
(14)
where ∗ denotes the convolution operator as usual, see also
[21, 26]. An alternative derivation of the same mathematical
result is presented in [20]. A historical overview of the
developmentoftheindicator-dilutiontheorywithnumerous
references to mathematical aspects can be found in [27].
Note that the solution of (14) with respect to CBF and other
clinically important perfusion parameters will be discussed
in Section 3.3.
From a physiological point of view, it would be more
meaningful to normalize CBF by the mass of the volume
V
∗
voi. This volume V
∗
voi contains the mass of the parenchyma
(andtheinterstitium)only.Inthatcase,CBFwouldbealocal
measure for the blood volume ﬂow per mass of parenchyma
(and interstitium) that actually requires blood supply for
oxygen and nutrient delivery. In (11), however, the volume
Vvoi also contains the mass of the blood-ﬁlled capillary bed
itself. Another aspect to consider is that the mean density
ρvoi of the volume, which inﬂuences the CBF value, actually
depends on the (varying) mass of the contrast agent in the
capillary bed. The alternative deﬁnition of CBF,
CBF
∗ =
F
V
∗
voi ·ρ
∗
voi
, (15)
would then lead to a corresponding alternative formulation
of the indicator-dilution theory,
c
∗
voi(t) = CBF
∗ ·ρ
∗
voi ·(cart ∗r)(t). (16)
From a practical perspective, however, it is more convenient
to use the deﬁnition of CBF given by (11), see Section 4.1.International Journal of Biomedical Imaging 7
The derivation of the indicator-dilution theory in this
section was focused on brain perfusion imaging. This the-
oretical model can be used in stroke patients if the BBB is
intact—compare Section 3.1—but it is not suited for semi-
permeable tumors, for example. With slight adaptations, this
theoretical model can also be applied in other applications
of perfusion imaging such as pulmonary perfusion imaging.
See [28] for detailed discussions. A discussion of models in
hepatic and renal perfusion imaging is given in [29, 30],
respectively.
In the context of perfusion measurement, the term
recirculation refers to the physiological phenomenon that,
due to the patient’s cardiac activity, the contrast agent passes
through the volume under consideration multiple times. It
can easily be shown, however, that there is no need to correct
for recirculation when deconvolution methods are applied to
determine perfusion parameters [31].
3.3. Computation of Perfusion Parameters Using Deconvolu-
tion. In (14), the variables cart(t)a n dcvoi(t) can be measured
and have known values whereas the values of CBF, r(t), and
ρvoi are unknown. In order to compute CBF as well as other
diagnostically relevant tissue perfusion parameters, we ﬁrst
need to introduce an intermediate variable, the ﬂow-scaled
residue function k(t),
k(t) = CBF ·ρvoi ·r(t), (17)
which is given in units of 1/s and can be determined directly
from the measured data cart(t)a n dcvoi(t). Using (17), (14)
can be written as
cvoi(t) = (cart ∗k)(t). (18)
Hence, k(t) can be obtained from the measured data cart(t)
and cvoi(t) using a deconvolution method. Since a fun-
damental property of the residue function r(t)i sr(0) =
max(r(t)) = 1, we may then determine CBF as
CBF =
1
ρvoi
·max(k(t)). (19)
Using max(k(t)) instead of k(0) has particular practical
advantages that will be discussed in detail in Section 4.1.
The ﬂow-scaled residue functionk(t) can further be used
to determine the MTT parameter of the tissue volume under
consideration. From (2), it follows that, for t>0, we have
dr(t)
dt
=− h(t). (20)
Equation (1) can thus be rewritten, and then using integra-
tion by parts and (17)a n d( 19), we obtain
MTT =
  ∞
0
τ
 
−
dr(τ)
dτ
 
dτ
=
  ∞
0
r(τ)dτ − lim
ξ →∞
 
τr(τ)|
ξ
0
 
=
  ∞
0
r(τ)dτ
=
1
max(k(τ))
·
  ∞
0
k(τ)dτ.
(21)
Note that we have assumed that there is a constant T>0
such that r(t) = 0f o rt>T . This assumption ensures that
lim
ξ →∞
 
τr(τ)|
ξ
0
 
= lim
ξ →∞
(ξr(ξ)) = 0. (22)
The cerebral blood volume (CBV) corresponding to the
tissue volume Vvoi represents another diagnostically relevant
perfusion parameter and is deﬁned as
CBV =
Vcap
ρvoi ·Vvoi
. (23)
ItquantiﬁesthebloodvolumenormalizedbythemassofVvoi
and is typically measured in units of mL/100g. The quantity
CBV can be computed from the parameters CBF and MTT
using the central volume theorem [22, 26], according to
which
CBF =
CBV
MTT
(24)
holds for the perfused volume of interest. Interestingly, this
theorem has been recognized for a long time and is already
foundinahistoricalpublicationfrom1893[32].Itstatesthat
theperfusionparametersCBVandCBFcorrespondingtothe
volume Vvoi of interest are related by the respective temporal
parameter MTT that quantiﬁes the mean time that a blood
cell needs to pass through its capillary bed. With (19)a n d
(21), it follows from (24) that
CBV = MTT · CBF =
1
ρvoi
·
  ∞
0
k(τ)dτ, (25)
which demonstrates that the CBV parameter can be derived
from the ﬂow-scaled residue function k(t)a sw e l l .
A healthy human brain exhibits a CBV of about 4mL/
100g for grey matter and a CBV of about 2mL/100g for
white matter [8].
Note that the deﬁnition of CBV that corresponds to the
alternative deﬁnition of CBF in [16]i s
CBV
∗ =
Vcap
ρ
∗
voi · V
∗
voi
. (26)
Accordingly, this alternative deﬁnition relates the blood
volume to the mass of the parenchyma (and the interstitium)
only and explicitly omits the mass of the capillary bed itself.
Furthermore, there are references in the literature that
suggest measuring the blood volume in units of mL/mL.
This alternative dimensionless quantity may therefore be
considered as a measure of blood (or vascular) volume
fraction. When relating the volume Vcap of the capillary bed
to the entire volume Vvoi of interest, a typical average ratio
of about 4% will result for the human brain. We refer to [33]
for both technical and clinical details.
3.4. Overview of Nondeconvolution-Based Methods for Per-
fusion Imaging. For the sake of completeness, this section
will brieﬂy cover two alternative approaches for CBV and
CBF estimation that are practical and relevant, and that do8 International Journal of Biomedical Imaging
not involve deconvolution operations. Nondeconvolution-
based methods for estimating perfusion parameters are also
referred to as direct measurement-based approaches [26].
Firstly, there is an alternative method to compute the
blood volume of the tissue volume under consideration
[1]. This approach assumes that the average contrast agent
concentration cvoi(t) in the tissue volume can be related
to the average contrast agent concentration ccap(t) in the
capillary bed by
cvoi(t) =
 
ρvoi · CBV
 
·ccap(t). (27)
According to the principle of conservation of mass, it follows
that
mc,tot = F
  ∞
0
cart(τ)dτ = F
  ∞
0
ccap(τ)dτ = F
  ∞
0
cven(τ)dτ,
(28)
wheremc,tot is the total mass of contrastagentthathas passed
through the volume of interest. This results in an alternative
expression for CBV,
CBV =
1
ρvoi
·
  ∞
0 cvoi(τ)dτ
  ∞
0 cart(τ)dτ
=
1
ρvoi
·
  ∞
0 cvoi(τ)dτ
  ∞
0 cven(τ)dτ
. (29)
Hence, assuming a suitable correction for contrast agent
recirculation[1,34],CBVcanbeestimatedfromtheintegrals
of either cvoi(t)a n dcart(t)o rcvoi(t)a n dcven(t) over time. See
[21] for details and further references with a particular focus
on MR perfusion measurements.
I ti sa r g u e di n[ 34] that, particularly for the case of CT
perfusion imaging of the brain, a physiologically reasonable
approximation to (29)i sg i v e nb y
CBV =
[cvoi(t)]max
[cven(t)]max
, (30)
which avoids the computation of the integrals over time and
only requires the maximum values of cvoi(t)a n dcven(t).
Secondly, there is a nondeconvolution-based approach
to estimate the blood ﬂow of the tissue volume under
consideration; the maximum slope method [22, 34]. The
derivationofthismethodisbasedon(4)andfurtherassumes
for simplicity’s sake that there is no venous outﬂow from
the tissue volume under consideration during the time of
observation; that is,
mc,voi(t) = mc,voi,in(t) = F ·
  t
0
cart(τ)dτ. (31)
Recalling the CBF deﬁnition—compare (11)—and that
mc,voi(t) = cvoi(t) · Vvoi,w eo b t a i n
cvoi(t) = ρvoi · CBF ·
  t
0
cart(τ)dτ. (32)
Taking the derivative of (32) yields
dcvoi(t)
dt
= ρvoi ·CBF ·cart(t), (33)
0
0
t
cmax
c(t)
AUC
TTP FM
of AUC
BAT
max. slope
centroid
Figure 5:Perfusionparametersthataremeasureddirectlyusingthe
time-concentration curve. See Sections 3.5 and 4.1 for explanations
(BAT: bolus arrival time, TTP: time-to-peak, FM: ﬁrst moment,
AUC: area under the curve).
and since (33)m u s th o l df o ra l lt, the blood ﬂow is given by
 
dcvoi(t)
dt
 
max
= ρvoi ·CBF ·[cart(t)]max, (34)
which means that CBF can be estimated by dividing the
maximum slope of the tissue time-concentration curve
cvoi(t), shown as an example in Figure 5, by the maximum
valueofthecontrastagentconcentrationcart(t)inthefeeding
artery.
An advantage of the maximum slope method is the
shorter overall acquisition time. As a downside, however, it
requires a faster contrast agent bolus injection rate in order
to approximately fulﬁll the no-venous-outﬂow condition.
Amorecomprehensivediscussionofthemaximumslope
method and a comparison with the deconvolution method
i sp r e s e n t e di n[ 35]. According to [35], the clinical results
based on these two approaches are generally of comparably
high quality in CT imaging applications. However, in cases
with insuﬃcient data quality (e.g., in terms of noise, contrast
agent concentration, bolus shape), deconvolution-based
methods may lead to superior results. Moreover, violation
of the aforementioned no-venous-outﬂow condition may
yieldincorrectperfusionestimateswhenthemaximumslope
methodisemployed.Thiscanhappenforpenumbralregions
of the brain which characterize the tissue at risk after an
ischemic stroke.
3.5. Additional Perfusion Parameters. Besides the aforemen-
tioned quantities CBV, CBF, and MTT, there are additional
perfusion parameters such as the time-to-peak (TTP) of
the time-concentration curve, the maximum contrast agent
concentration cmax, as well as the ﬁrst moment (FM) of the
time-concentration curve, for example. The ﬁrst moment
canbecomputedbyprojectingthecentroidoftheareaunder
the curve (AUC) of the time-concentration curve onto the
time axis.
Figure 5 illustrates the quantities cmax,T T P ,a n dF M .
The remaining parameter bolus arrival time (BAT) will be
explained in Section 4.1. In practicalmeasurements, the time
point t = 0 represents the start of the scanning. A detailedInternational Journal of Biomedical Imaging 9
Table 2: Summary of perfusion parameters and how these param-
eters can be estimated using deconvolution-based and nondecon-
volution-based methods.
Parameter w/Deconvolution w/o Deconvolution
CBV (1/ρvoi) ·
  ∞
0 k(τ)dτ (1/ρvoi) ·
  ∞
0 cvoi(τ)dτ/   ∞
0 cart(τ)dτ
CBF (1/ρvoi) ·max(k(t)) (1/ρvoi) ·[dcvoi(t)/dt]max/
[cart(t)]max
MTT
  ∞
0 k(τ)dτ/max(k(τ)) see comment in Section 3.5
TTP — arg maxt(cvoi(t))
FM —
  ∞
0 cvoi(τ)τdτ/
  ∞
0 cvoi(τ)dτ
description and analysis of these additional quantities,
however, is beyond the scope of this paper. A comparison of
several perfusion parameters and their clinical impact on the
treatment of stroke patients is given in [36].
In summary, Table 2 covers the most common diag-
nostically relevant perfusion parameters and shows how
they can be determined employing deconvolution-based
and nondeconvolution-based methods. In principle, the
central volume theorem—compare (24)—may also be used
to numerically estimate the MTT from the parameters
CBF and CBV when the latter have been computed using
nondeconvolution-based algorithms. However, the authors
are not aware of any reference that describes the application
of this approach in clinical practice.
4. PracticalImplementation
This section is devoted to the practical computer imple-
mentation of algorithms for perfusion image analysis. First,
we will discuss the necessary adaptations of the theoretical
model from Section 3 that are needed for its application to
data from real CT and MR scanners. Afterwards, we will
describe commonly used algebraic deconvolution methods
and also give an overview of alternative approaches. We will
motivate the need for suitable regularization and discuss the
inﬂuence of the regularization parameter on the resulting
perfusion estimates. For the sake of completeness, we will
alsoaddresstechniquesforthepre-processingoftheacquired
perfusion data.
4.1. Adaptations of the Model of Microcirculation. In Sec-
tion 3.1, we presented a model of microcirculation at the
tissue level. We have assumed that we can measure the
average contrast agent concentration cvoi(t) corresponding
to a volume Vvoi under consideration which is supplied by
onesinglecapillarybedonly.Furthermore,wehavesupposed
that we can measure the contrast agent concentration cart(t)
locally at the arterial inlet into the capillary bed. However,
real CT and MR scanners are characterized by limited spatial
(and contrast) resolution and, in reality, one cannot rely
on these two aforementioned assumptions. We will thus
introduce two major adaptations of the physiological model
which are necessary once it is to be applied to data from real
scanners.
First, during a standard CT and MR perfusion exam, a
volume of interest is scanned and the data is reconstructed
on a grid of regularly spaced voxels. In the object domain,
each voxel volume Vvox (Vvox   Vvoi) contains numerous
capillary beds as well as arterioles and venules that supply
anddrainthesecapillarybeds,respectively.Fortheparticular
case when the volume Vvox is located completely within a
larger artery or vein, there are of course no capillary beds
located within Vvox.
The measured signal (X-ray attenuation or MR relax-
ation rate) in a voxel is thus a combination of the signals
from both the capillary beds as well as the arterial and
venous vessels [37]. The perfusion parameters that are
computed from the voxel’s time-concentration curve are
therefore not true parameters of the capillary perfusion. If
no larger artery or vein is located inside the volume Vvox,w e
may adapt the model introduced in Section 3.1 as follows:
the measured time-concentration curve cvoi(t) refers to the
average perfusion from the arterioles through the capillary
beds to the venules found in Vvox.
The second adaptation of the model concerns the
measurement of cart(t). In reality, it is not possible to locally
measure the concentration at the arterial inlet into the
volume Vvox.I n s t e a d ,i ti sc o m m o np r a c t i c et h a tag l o b a l
arterial input function (AIF) is chosen in a large arterial
vessel. In brain perfusion imaging, for example, the anterior
cerebral artery is often selected [38].
This approach leads to a traveling time of the contrast
agentbolusfromwheretheAIFismeasuredtothelocationof
the tissue volume where cvoi(t) is measured. We will refer to
this traveling time as the bolus delay. Another physical eﬀect
that needs to be taken into consideration is bolus dispersion
[39]. It appears as a widening of the shape of the bolus that is
caused during the ﬂow from the remote AIF location to the
measurement site of cvoi(t).
The bolus delay has two implications. First, the curve
cvoi(t) does not start to rise at the same time point as cart(t)
starts to rise. The diﬀerence between these two time points
c a nb ed e ﬁ n e da st h eb o l u sa r r i v a lt i m e( B A T ) ,w h i c hm a y
be considered as an additional perfusion parameter [40].
Alternatively, the BAT can be deﬁned as the time interval
between the start of the scanning and the time when cvoi(t)
begins to rise, see Figure 5. The results obtained with this
alternative deﬁnition diﬀer from the results obtained with
the ﬁrst deﬁnition by a constant value only.
Second, the ﬂow-scaled residue function k(t)i se q u a lt o
0f r o mt = 0t ot = BAT. In addition, due to the bolus
dispersion, k(t) will not rise instantaneously to its maximum
at t = BAT, but it will have a ﬁnite rise time. The time-
to-maximum (TMAX) of the ﬂow-scaled residue function,
deﬁned as
TMAX = arg max
t
(k(t)), (35)
has also been suggested as an additional perfusion parameter
[41, 42]. Since the function k(t)c a nb e0a tt = 0( d u et o
bolus delay), it is reasonable and recommended to estimate
CBFasthemaximumofk(t)—compare(19)—andnotasthe
value of k(t)a tt i m et = 0.10 International Journal of Biomedical Imaging
Bolus delay and dispersion may lead to an underesti-
mation of CBF [39] .I no r d e rt oc o r r e c tf o rb o l u sd e l a y
and dispersion several methods have been proposed [43,
44]. The use of local arterial input functions could also
reduce the eﬀect of bolus dispersion, see Section 4.5.6.O n
the other hand, new perfusion parameters (BAT, TMAX)
are motivated by these two eﬀects and can be deﬁned
accordingly. They represent perfusion characteristics related
to the ﬂow of the contrast agent bolus from the selected
feeding artery to the respective tissue site, see again Figure 5.
4.2. Deconvolution Using Algebraic Methods. In this section,
we will discuss the robust numerical solution of the main
equation of the indicator-dilution theory—(18)—by means
of algebraic deconvolution methods. An overview of further
deconvolution methods will then be given in Section 4.3.
We will introduce the discretization of (18) and show that
its solution without regularization leads to nonphysiological
results. We will explain and motivate suitable regulariza-
tion approaches by a singular value decomposition-based
analysis. To illustrate the mathematical concepts, we will
provide examples using the time-attenuation curves μart(tj)
and μvoi(tj) shown in Figure 6 that were extracted from a real
perfusion CT scan.
We assume that the measured time-attenuation curves
can be converted to time-concentration curves using a
constant of proportionality of 1g/mL/HU. Details about
the conversion, also discussing perfusion MR data, will be
explained in Section 4.5.4.
In practice, the time-concentration curves cart(t)a n d
cvoi(t) are sampled at discrete time points. We denote these
time points as tj = (j − 1) · Δt with j = 1,...,N. A typical
value of the sampling period Δt is 1s, for example. We can
discretize (18)a s
cvoi
 
tj
 
=
  ∞
0
cart(τ)k
 
tj −τ
 
dτ ≈ Δt
N  
i=1
cart(ti)k
 
tj−i+1
 
,
(36)
see [45]. We assume that the values of cart(t)c a nb en egl e ct e d
for t>N Δt. Since k(t) = 0f o rt<0, the end summation
index could also be set to j instead of N. By rewriting this
expression using matrix-vector notation, we obtain
Δt ·
⎛
⎜ ⎜ ⎜ ⎜ ⎜ ⎜ ⎜
⎝
cart(t1) 0 ··· 0
cart(t2) cart(t1) ··· 0
. . .
. . .
...
. . .
cart(tN) cart(tN−1) ··· cart(t1)
⎞
⎟ ⎟ ⎟ ⎟ ⎟ ⎟ ⎟
⎠
⎛
⎜ ⎜ ⎜ ⎜ ⎜ ⎜ ⎜
⎝
k(t1)
k(t2)
. . .
k(tN)
⎞
⎟ ⎟ ⎟ ⎟ ⎟ ⎟ ⎟
⎠
=
⎛
⎜ ⎜ ⎜ ⎜ ⎜ ⎜ ⎜
⎝
cvoi(t1)
cvoi(t2)
. . .
cvoi(tN)
⎞
⎟ ⎟ ⎟ ⎟ ⎟ ⎟ ⎟
⎠
,
(37)
or shortly
Ak = c, (38)
where Δt and cart(tj) are contained in the matrix A ∈ RN×N,
and k(tj)a n dcvoi(tj) represent the entries of the vectors
k ∈ RN and c ∈ RN,r e s p e c t i v e l y .D i ﬀerent ways to discretize
(18) are investigated in [46]. For example, it was suggested in
[47,48]touseadiscretizationmethodwithablock-circulant
matrix A in order to reduce the inﬂuence of the bolus delay.
See the appendix for details.
A standard approach to solve (37)f o rk is to use the
singular value decomposition (SVD) of A.F o ram a t r i xA ∈
RN×N with r = rank(A) linearly independent rows and
columns, it is deﬁned as
A = UΣVT =
r  
i=1
uiσivT
i , (39)
where U = [u1,...,ur]a n dV = [v1,...,vr] are unique
orthogonal matrices composed of the left and right singular
vectors ui and vi,r e s p e c t i v e l y[ 49] .T h en u m b e ro fr o w sa n d
columns in A that only contain zeros is determined by the
numberNlz ofleadingzerosintheseriescart(tj), j = 1,...,N.
Therefore,Ahasrankr ≤ N−Nlz.Afterthesubtractionofthe
baseline, it may happen that the ﬁrst entry cart(t1) is zero, see
Section 4.5.4, and that A thus becomes rank-deﬁcient. The
diagonal matrix Σ = diag(σ1,...,σr) contains the singular
values σi in nonincreasing order σ1 ≥ σ2 ≥ ··· ≥ σr > 0.
The least-squares solution kls of (38) using the SVD of A is
given by
kls =
r  
i=1
uT
i c
σi
vi, (40)
see again [49]. Note that the unique vector kls is referred
to as least-squares solution since determining it from (40)
is equivalent to minimizing the squared Euclidean residual
norm of the linear systems given by (37)a n d( 38); that is,
kls = arg min
k∈RN
 
 Ak −c 
2
2
 
. (41)
However, the least-square solution kls does not represent
as u i t a b l es o l u t i o no f( 38)i ft h em a t r i xA is ill-conditioned.
It can be shown that a matrix A with a structure as shown
in (37)o r( A.3), also known as a Toeplitz matrix, is in fact
ill conditioned [50, 51]. In that case, a small change in c
(e.g., due to projection noise) can cause a large change in kls.
T h er a t ea tw h i c hac h a n g ei nc inﬂuences the solution kls is
roughly proportional to the condition number of A,d e ﬁ n e d
as σ1/σr [49].
As an example, Figure 7 shows the solution kls of the
example data from Figure 6. The solution is strongly
oscillating and even has a rising amplitude. It is obvious
that this solution has nothing in common with the real
physiological behavior of the ﬂow-scaled residue function.
In order to get a better understanding of why kls is not
a meaningful solution and to motivate the regularization
approach,wewillinvestigatetheindividualtermsof (40).We
use the data shown in Figure 6 to obtain A and c. Figure 8
represents a plot of the absolute values of the expressions
(uT
i c)/σi that occur in (40). These factors weight the right
singular vectors vi of A.International Journal of Biomedical Imaging 11
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Figure 6: Examples of measured time-attenuation curves in perfusion CT in (a) an arterial vessel and (b) in tissue. The time curves have
been pre-processed by baseline subtraction and removal of the baseline time frames. The example data is measured at N = 35 discrete time
points.
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Figure 7: Least-squares solution vector kls of (38) using the example data from Figure 6.( kls)j denotes the jth entry of the vector kls.T h e
plot shown in (a) illustrates the strong oscillations of kls. The plot given in (b) shows the amplitude |kls| of this function on a logarithmic
scale.
It is known from numerical analysis that the discrete
Picard condition represents a means to analyze discrete ill-
conditioned problems [50, 51]. This condition is violated, if
the expressions uT
i c do not decay faster, on average, than the
singular values σi until a threshold value is reached where the
singular values level oﬀ. The reader is referred to [51]f o ra
more detailed explanation of the discrete Picard condition
and its relation to the Picard condition from which it is
derived.AusualreasonfortheviolationofthediscretePicard
condition is noise in the measured data that the matrix A
is based on. We can see that the discrete Picard condition
is actually violated in the example shown in Figure 8 [52].
Consequently, the absolute values of the ratios (uT
i c)/σi—
which represent the weighting factors of the right singular
vectors vi—become very large.
To obtain a numerically stable result, a ﬁlter is used
for regularization. The ﬁlter should suppress the inﬂuences
of small singular values σi or, equivalently, the inﬂuences
of high absolute values of the weighting factors (uT
i c)/σi.
The regularized solution kλ,w h e r eλ is a regularization
parameter, is given by
kλ =
r  
i=1
 
fλ,i
uT
i c
σi
 
vi. (42)12 International Journal of Biomedical Imaging
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Figure 8: SVD analysis of the matrix A constructed from the
example data shown in Figure 6. The plot displays the absolute
values of the weighting factors (uT
i c)/σi and of their individual
components |uT
i c| and σi on a logarithmic scale.
We will focus on two common deﬁnitions of the ﬁlter
factors fλ,i. Firstly, the ﬁlter factors f
(tsvd)
λ,i correspond to the
truncated singular value decomposition (TSVD) approach
and are deﬁned with a sharp threshold at λ,
f
(tsvd)
λ,i =
⎧
⎨
⎩
0, for σi <λ ,
1, for σi ≥ λ.
(43)
Secondly, the ﬁlter factors f
(tikh)
λ,i are based on the Tikhonov
regularization approach and characterized by a smooth
weighting function centered around λ,
f
(tikh)
λ,i =
σ2
i
σ2
i +λ2. (44)
The (absolute) regularization parameter λ is usually
computed relative to the maximum singular value σ1, that
is,
λ = λrelσ1. (45)
The relative regularization parameter λrel is supposed to lie
in the interval between 0 and 1.
I no r d e rt oi l l u s t r a t et h eT i k h o n o vﬁ l t e rf a c t o r s ,F i g u r e9
shows a plot of the function f
(tikh)
λ = σ2/(σ2 + λ2)w h i c h
is—unlike (44)—deﬁned for a continuous range of σ.F o r
determining f
(tikh)
λ ,w ea s s u m e dσ1 = 1. It can be seen that,
for increasing λ (i.e., stronger regularization), the values of
f
(tikh)
λ decrease for all σ.
Interestingly, the solution k
(tikh)
λ of (38) using the ﬁlter
factors f
(tikh)
λ,i is equivalent to minimizing the weighted sum
of the squared Euclidean residual norm  Ak − c 2
2 and the
squared Euclidean solution norm  k 
2
2; that is,
k
(tikh)
λ = arg min
k∈RN
 
 Ak −c 
2
2 +λ2 k 
2
2
 
. (46)
Figure 10(a) shows the solution k
(tikh)
λ computed for two
diﬀerent regularization parameters. The solution for λrel =
0.1 still shows some nonphysiological oscillations. However,
the solution for λrel = 0.3 can in fact be interpreted as a
ﬂow-scaled residue function in the presence of bolus delay
and dispersion, compare Section 4.1. Figure 10(b) illustrates
a plot of max(k
(tikh)
λ ), which is proportional to CBF (see
Section 3.3 and Table 2), as a function of λrel.A p p a r e n t l y ,
CBF depends on the choice of regularization parameter.
Choosing an optimal regularization parameter that will lead
to physiologically reasonable estimates will be discussed in
Section 4.4.
4.3. Alternative Deconvolution Approaches. The algebraic
deconvolution approach from Section 4.2 is very com-
monly applied to analyze perfusion data. Yet, deconvolution
problems arise in many other applications, and numerous
alternative algorithms to solve these problems have been
developed [53] .I nt h i ss e c t i o n ,w ep r o v i d eab r i e fo v e r v i e w
of alternative deconvolution approaches that have also been
applied to perfusion data.
The Fourier transform represents a standard method to
solve deconvolution problems [54], and it has also been
evaluatedtoanalyzeperfusiondata[45,55–57].Interestingly,
the Fourier transform-based deconvolution approach is
mathematically equivalent to the SVD-based deconvolution
approach with a block-circulant matrix A, compare the
appendix [47, 58–60]. However, results obtained with SVD-
based and FT-based deconvolution can be diﬀerent because
the chosen regularization approaches for these two methods
are usually not equivalent. The regularization in the con-
text of the Fourier-based deconvolution approach can be
implemented by means of a modiﬁed Wiener ﬁlter [55], for
example. The reader is referred to [60, 61] for a detailed
analysis of the equivalence of SVD-based and Fourier-based
regularization approaches.
In contrast to the model-independent deconvolution
approaches also model-dependent approaches exist. Model-
dependent approaches assume a certain shape of the residue
function. For example, in [45, 62] a decaying exponential
function was used which makes the deconvolution more
stable since it reduces the degrees of freedom of the residue
function [45]. However, if the underlaying residue function
isdiﬀerentfromthemodeltheperfusionparametersmaynot
be estimated correctly.
Deconvolution using orthogonal polynomials was inves-
t i g a t e di n[ 63]. An iterative deconvolution algorithm based
on maximum likelihood expectation maximization (ML-
EM) algorithm was proposed in [64]. An approach using
Gaussian processes was evaluated in [65]. The deconvolution
algorithm in [66] uses a nonlinear stochastic regularization
method.
A comprehensive comparison of all available deconvolu-
tion methods has not been carried out yet. The SVD-basedInternational Journal of Biomedical Imaging 13
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Figure 9: (a) Linear and (b) double logarithmic plot of the Tikhonov ﬁlter factor f
(tikh)
λ as a function of the singular value σ ∈ [10−5,1].
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Figure 10: Deconvolution with Tikhonov regularization: (a) Regularized solution k
(tikh)
λ for two diﬀerent regularization parameters λrel and
(b) maximum of k
(tikh)
λ as a function of λrel.( k
(tikh)
λ )j denotes the jth entry of the vector k
(tikh)
λ .
deconvolution approach, which is available in several soft-
ware packages [67–69], is comparably simple to implement
and can be considered as the current standard method in
perfusion image analysis.
4.4. Determination of the Regularization Parameter. Fig-
ure 10(b) demonstrated that (the maximum of) the solution
k
(tikh)
λ depends on the regularization parameter λrel.C o n -
sequently, the computed perfusion values—which can be
derived from k
(tikh)
λ according to Table 2—vary for diﬀerent
λrel. As an example, the CBF value will be underestimated
systematically for large λrel.
Therefore, an optimal choice of λrel is crucial. A simple
approach is to empirically determine a ﬁxed value λrel. This14 International Journal of Biomedical Imaging
approachisoftenusedinpractice,andatypicalvalueinbrain
perfusion CT is, for example, λrel = 0.2[ 68]. However, there
exist more sophisticated approaches as well to determine
the values λrel independently for each voxel position [70].
Sincetherequiredamountofregularizationdependsroughly
on the signal-to-noise ratio (SNR), these approaches can be
more ﬂexible when the SNR is spatially variant.
In [45, 47, 48], an oscillation index (OI) was deﬁned
to determine the intensity of oscillations of the ﬂow-scaled
residue function. The regularization can then be varied until
the OI value falls below a certain threshold.
The L-curve criterion represents a model-independent
method to determine λ (and λrel)[ 31, 71, 72]. The L-
curve is deﬁned by a double logarithmic plot of the squared
Euclidean norm  kλ 2
2 of the solution versus the squared
Euclidean norm  Akλ − c 2
2 of the residual for a range of
diﬀerent λ values. The optimal regularization parameter λopt
canbefoundatthelocationofthecharacteristiccornerpoint
of the L-curve.
Another method to determine an appropriate regulariza-
tion parameter is generalized cross-validation as described in
[50, 73]. An implementation of the L-curve method and the
generalized cross-validation can be found in [52].
Furthermore, a parameter estimation method that uses a
priori knowledge of the behavior of the residue function was
proposed in [74].
Kudo et al. [68] reported that two manufacturers applied
a ﬁxed threshold value λrel in their perfusion analysis
software. Unfortunately, the clinical use of methods with
adaptive threshold values is rarely described in the current
literature.
4.5. Perfusion Data Preprocessing. This section gives an over-
view of pre-processing techniques that can be applied in
order to enhance the quality of the estimated perfusion
parameters. Pre-processing occurs prior to the deconvo-
lution step which may be implemented as described in
Section 4.2.
A simple, yet mandatory, pre-processing step consists
of the conversion to contrast agent concentration values,
see Section 4.5.4. Further pre-processing steps are used
to enhance the image quality (e.g., noise reduction) and
to correct for artifacts (e.g., motion correction, partial
volume correction) and speciﬁc properties of the blood
(e.g., correction of diﬀerences in hematocrit). There are also
pre-processing steps that can optimize the analysis of the
perfusionvaluemaps(e.g.,segmentationofcertainanatomic
structures) and the application workﬂow (e.g., automated
AIF estimation).
The order of the pre-processing steps presented in this
section can act as a guideline for their practical imple-
mentation. However, a diﬀerent ordering can of course be
reasonable as well. Finally, this overview cannot include all
details regarding suitable pre-processing steps. The reader is
referred to the available literature for in-depth discussions.
4.5.1. Motion Correction. Patient motion (e.g., due to head
movement or breathing) can result in a sudden change
of the attenuation values at the ﬁxed (stationary) voxel
positions.Sincethischangeintheattenuationvalueiscaused
by motion and not by contrast agent ﬂow, the computed
perfusion values can be severely biased. A practical approach
for motion correction is to register all time frames of the
reconstructed data set onto the ﬁrst time frame [75]. A
3D registration should be used because it can also correct
motion that occurs perpendicular to the orientation of the
reconstructed slices. For a brain perfusion scan, a rigid
registration may be suﬃcient. Conversely, in abdominal
perfusion imaging, a non-rigid registration may be better
suited to compensate for the deformations due to breathing.
As an alternative to registration, use of groupwise
motion correction based on an optimization of a global
cost function has been suggested [76]. There are also several
approaches for motion correction in fMRI data [77]. These
approaches may be used for perfusion MR data as well
since both types of data typically consist of T2∗-weighted
EPI images [78]. However, the dynamic signal changes are
relatively higher in DSC-MR data when compared to fMRI
data [78]—in particular during the contrast agent bolus
passage—which must be taken into account when adapt-
ing fMRI-based motion correction algorithms to DSC-MR
data.
A related issue is streak artifact in reconstructed per-
fusion CT images that are caused by patient motion that
occurs while the projection data corresponding to a single
time frame is acquired. In perfusion MR images, ghosting
artifacts can arise if the patient moves during the data acqui-
sition. These kinds of artifact cannot be corrected by inter-
frame motion correction. Instead, dedicated reconstruction
algorithms would be required. As a practical alternative,
time frames that exhibit severe reconstruction artifacts
may simply be removed from the data set (i.e., from the
series of successive time frames), which corresponds to the
elimination of invalid sampling points of the voxel-speciﬁc
time-concentration curves.
4.5.2. Noise Reduction. In the course of a perfusion exam,
the measured signal in tissue that is caused by the contrast
agent ﬂow can be very low. For the case of perfusion
CT, for example, tissue enhancements of less than 10HU
are measured. Hence, noise in the reconstructed images
can be of a similar order of magnitude as the signal in
tissue itself. Consequently, noise reduction should be taken
into consideration in order to improve the accuracy of the
estimated perfusion parameters.
Noisereductioncanbeimplementedasaspatialsmooth-
ing of the data. Using a basic approach, each time frame
can be ﬁltered independently of the other time frames, and
linear isotropic ﬁlters (e.g., based on a Gaussian ﬁlter kernel)
maybeapplied.Alternatively,anisotropicﬁltersthatpreserve
edgesandavoidblurringoflargevesselscanalsobeemployed
[79].
Both linear and nonlinear ﬁltering in the tempo-
ral dimension—that is, between successive time frames—
represent further methods for noise reduction [80]. It
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the deconvolution step is equivalent to linear ﬁltering in the
temporal domain.
Recently, sophisticated 4D ﬁltering techniques have been
proposed that perform ﬁltering in both the spatial and the
temporal dimension and that are optimized for perfusion
data [81, 82]. Fitting of the time-concentration curves to a
model function such as a gamma-variate function is also a
means for noise reduction [75].
4.5.3. Segmentation. A segmentation of certain anatomic
structures in the reconstructed data set can optimize the
perfusion image analysis [69, 83]. For example, the time-
concentration curves could then be analyzed only in regions
of interest where blood ﬂow is actually expected [84]. Other
regions such as air, bone, cerebrospinal ﬂuid (CSF), and
calciﬁcations can be neglected. A segmentation and the
subsequent removal of vessels is useful in order to optimize
the quantitative analysis of perfusion parameters in tissue.
Such a vessel segmentation can be performed prior to the
deconvolution step, but it can also be implemented as a
postprocessing step as described in [85].
4.5.4. Conversion to Contrast Agent Concentration. Neither
for the case of CT imaging nor for the case of MR imaging
can the time-concentration curves cart(t)a n dcvoi(t)b e
measured directly. Instead, the measurement is a super-
position of the signal from the tissue itself and the con-
trast agent. Since the deconvolution approach presented in
Section 4.2 expects that the functions cart(tj)a n dcvoi(tj)
only refer to the signal caused by the contrast agent, the
tissue signal must be subtracted. Furthermore, the measured
signal must be converted to a contrast agent concentration
value.
In perfusion CT, it is assumed that the (underlying) con-
trast agent concentration value is proportional to the (mea-
sured) X-ray attenuation value [86, 87]. Since deconvolution
is a linear operation, the constant of proportionality does
not inﬂuence the computed ﬂow-scaled residue function. It
can also be seen that the additional perfusion parameters
from Section 3.5 are independent of this constant. Therefore,
this constant is usually set to kct = 1g/mL/HU for the
sake of simplicity. The baseline value μ0 can be computed
as the mean of μ(tj) during the B acquired time frames
before the contrast agent bolus arrives in the arterial input
function. The conversion formula from an attenuation
value μ(tj) (corresponding to a particular voxel) into the
respectivecontrastagentconcentrationvaluec(tj)thenreads
as
c
 
tj
 
= kct
 
μ
 
tj+B−1
 
−μ0
 
,
μ0 =
1
B
B  
i=1
μ(ti).
(47)
In perfusion MR, however, the contrast agent concen-
tration value is not proportional to the received signal s(tj)
(in one voxel). Instead, it can be determined using the
following formula:
c
 
tj
 
=−
kmr
TE
ln
⎛
⎝
s
 
tj+B−1
 
s0
⎞
⎠,
s0 =
1
B
B  
i=1
s(ti),
(48)
see [21]. Here, kmr is a constant of proportionality which—
with a similar argument as for kct—can have a norm of 1 and
TE is the echo time of the MR sequence. It must be noted,
however, that the constant kmr can be diﬀerent for blood and
tissue due to diﬀerences in T2∗ relaxivities [37, 88]. This
complicates absolute quantiﬁcation of cerebral perfusion
as discussed in [89]. Furthermore, studies have shown
that fully oxygenated blood, for example, demonstrates a
nonlinear relationship between the measured diﬀerence in
T2∗ relaxation rate and contrast agent concentration [90].
Note that if only one time frame is considered as the
baseline (i.e., if B = 1), then c(0) = 0, and the matrix
A deﬁned by (37)a n d( 38) will be rank deﬁcient, compare
Section 4.2.
4.5.5.CorrectionofHematocritDiﬀerences. Hematocrit(Hct)
is a value that describes the proportion of the blood that
consists of red blood cells. Hct is higher in arteries than
in capillaries. Consequently, the proportion of the plasma
in the blood, given by the diﬀerence (1-Hct), has a higher
value in capillaries than in arteries. Since the contrast agent
is distributed in the plasma only, the amount of plasma has
a direct inﬂuence on the measured Hounsﬁeld value or MR
relaxation rate.
If the Hct diﬀerence is not corrected, it may bias the
absolute quantiﬁcation of the contrast agent concentration.
A constant dimensionless correction factor κ,d e r i v e df r o m
the known Hct values in arteries and capillaries (often set to
κ = 0.73) has been proposed [22, 85]. The measured time-
concentration curve cvoi(t) is then multiplied with κ to avoid
the bias due to diﬀerent Hct values.
4.5.6. Automated AIF Estimation. The total time for the
perfusion image analysis can be shortened and the analysis
can be made user independent by an automated estimation
of the arterial input function. Several methods have been
proposed that detect one global AIF [91–93].
An interesting alternative approach is to estimate several
local AIFs, which would be better suited to the theoretical
model that was introduced in Section 3 [94–96]. Since the
local arteries are often small, this approach can have several
disadvantages [89]. For example, partial volume eﬀects—
compare Section 4.5.7—can be more severe when compared
to choosing one global AIF in a larger vessel. Perfusion
analysis using local AIFs is actually investigated in [97]
and the authors state that it produced more useful CBF
maps.
Besides the arterial input function cart(t) the venous
outﬂowfunction cven(t)couldalsobedetectedautomatically.16 International Journal of Biomedical Imaging
Knowledge about the venous outﬂow function could be used
to automatically correct for partial volume eﬀects which are
described next.
4.5.7. Correction of Partial Volume Eﬀects in the AIF. Due
to limited spatial resolution in reconstructed perfusion CT
and MR data, the AIF can suﬀer from partial volume eﬀects
[26]. This eﬀect can lead to an underestimation of the AIF
and consequently to incorrect perfusion values. To correct
for partial volume eﬀects in the AIF, several methods have
beenproposed[98–100].Commonly,thepeakconcentration
valuewithinalargervenousvesselortheareaunderthecurve
of a large venous vessel is used to rescale the AIF [31].
5. Summary
We have presented an overview of algorithms for the estima-
tion of the most prominent perfusion parameters from CT
or MR measurements that play an essential role in the assess-
ment of ﬂow altering diseases such as stroke, for example. In
particular, we have emphasized the class of deconvolution-
based methods that result from the application of the
indicator-dilution theory, which is also derived in detail.
Alternative approaches that do not use a deconvolution
method are addressed brieﬂy as well. The robust numerical
solutionoftheresultingsystemoflinearequationsrepresents
the second major topic of this paper. We have included a
detailed discussion regarding the application of the singular
value decomposition method as well as the practically
relevant introduction of a suitable regularization technique
in order to avoid physiologically unrealistic behavior of the
estimated solution. Since this paper is intended to provide
an introduction both to the underlying theory and to
implementation-relevant aspects, we have provided a survey
of preprocessing techniques that should be considered when
designing a clinically useful tool for CT or MR perfusion
analysis.
The novel contribution of this paper is to present the
fundamental model, the mathematical deconvolution with
regularization, and the practical pre-processing steps in one
place. For a thorough understanding of perfusion image
analysis, knowledge of all of these aspects is important and
we have elaborated several links between these topics.
Appendix
The matrix A in (38) can be replaced by a block-circulant
matrix Acirc to reduce the inﬂuence of the bolus delay,
compare Section 4.1, and thus to become independent of
time shifts in the tissue time-concentration curve. Several
studies actually exhibited an improvement of the accuracy
of the perfusion estimates when using this alternative
discretization method compared to the approach given by
(36)[ 47, 48, 101]. On the other hand, in a receiver operating
characteristics analysis—concerning infarct prediction in
acute stroke patients—both discretization methods led to
almost equal results [36].
The elements ai,j of A ∈ RN×N—with i denoting the row
index (i = 1,...,N)a n dj denoting the column index (j =
1,...,N) as usual—are deﬁned as
ai,j =
⎧
⎪ ⎨
⎪ ⎩
Δtcart
 
ti−j+1
 
,f o r j ≤ i,
0, for j>i ,
(A.1)
see (37). In order to assemble the block-circulant matrix
Acirc,thesizeofthetimeseriescart(tj)mustbeincreasedfrom
N to M (M ≥ 2N) using zero padding. We denote the new
zero-paddedtimeseriesas   cart(tj).Thesiz eofcvoi(tj)m ustbe
changed accordingly in order to retain consistency in (38).
The elements (acirc)i,j of the block-circulant matrix
Acirc ∈ RM×M can then be deﬁned as
(acirc)i,j =
⎧
⎪ ⎨
⎪ ⎩
Δt  cart
 
ti−j+1
 
,f o r j ≤ i,
Δt  cart
 
tM+i−j+1
 
,f o r j>i .
(A.2)
As an example, for M = 2N, the matrix Acirc has the
following structure:
Acirc = Δt
⎛
⎜ ⎜ ⎜ ⎜ ⎜ ⎜ ⎜ ⎜ ⎜ ⎜ ⎜ ⎜ ⎜ ⎜ ⎜
⎝
cart(t1) 0 ··· 0 0 cart(tN) ··· cart(t2)
cart(t2) cart(t1) ··· 0 00 ··· cart(t3)
. . .
. . .
...
. . .
. . .
. . .
...
. . .
cart(tN) cart(tN−1) ··· cart(t1) 00 ··· 0
0 cart(tN) ··· cart(t2) cart(t1) 0 ··· 0
00 ··· cart(t3) cart(t2) cart(t1) ··· 0
. . .
. . .
...
. . .
. . .
. . .
...
. . .
00 ··· 0 cart(tN) cart(tN−1) ··· cart(t1)
⎞
⎟ ⎟ ⎟ ⎟ ⎟ ⎟ ⎟ ⎟ ⎟ ⎟ ⎟ ⎟ ⎟ ⎟ ⎟
⎠
. (A.3)
The horizontal and vertical lines drawn in (A.3)s u b -
divide the matrix into four quadrants. As can be seen, the
matrix A is a submatrix of Acirc, and it appears in the upper
left and lower right quadrant.International Journal of Biomedical Imaging 17
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